"Welcome To Our Company"
The Cannabis Industry has seen explosive growth . Medicinal Cannabis Sales are already nearly 7 Billion this Year moving to over 20 Billion in the next 4-5 years. Estimates are 36 billion by 2020. Across all medical cannabis laws in the United States, cannabis is legally recognized as a form of therapy or medicine for more than 50 qualifying conditions, including Alzheimer’s disease, anorexia, arthritis, cancer, chronic pain, epilepsy and post-traumatic stress disorder. President trump, is "in favor of medical marijuana 100%." Effectively legalizing medical cannabis at the national level would allow physicians the ability to write prescriptions for marijuana, and it would open the floodgates to medical research into cannabis, granting easier access to researchers, universities, and drug companies. President Trump has always supported states rights to choose their own pathway to legalized marijuana.
See what we provide for you
Doctors now have access to decision making tools which lessens their reliance on experimentation and guesswork, and improves their confidence in consistent and personalized cannabis treatments.
Patients access to APP
A Beta launch will happen in the Summer of 2018. It should result in thousands of new social media followers and newsletter subscribers, dozens of strategic partnerships and qualified investor leads, and feature stories from in top media publications.
Dispensary access to data
Our industry specific, cloud-based platform has been developed with robust artificial intelligence and data mining capabilities, positioning the company as the WebMD of the cannabis industry.
We seek to fill that need by creating the industry standard for cannabis-related advice, selection, terminology, and data, all without touching the actual plant – enabling the Company to work in any regulatory environment.
Easy access technology
Our product and technology strategy uses pre-existing, fully-vetted and IP-protected technologies – adapted and applied to the cannabis segment – and the Company maintains exclusive and royalty-free licenses to the various complementary technologies that serve as our building blocks.
Dr. Michael Stem
Michael Stem graduated from medical school in 1971 and since 1983 has been a board-certified urologist and urological surgeon. Dr. Stem served as an adjunct clinical faculty member at Bast-yr University School of Naturopathic Medicine 11 years (1995-2006). Dr. Stem operates the Northwest Healthy Options Clinic in Seattle, Washington. Dr Stem continues advising patients on lifestyle issues and alternative healthy treatments for wide variety of diseases, including medical cannabis.
Dr. Bindiya Moorjani
Dr. Bindiya Moorjani was a awarded a Ph. D. in biomedical sciences from the Fishberg Research Center for Neurobiology, Mount Sinai School of Medicine, New York University. Dr. Moorjani has authored several scientific studies that have been published in scientific journals. She did major studies on Serotonin. From 1993 through 1999, Dr. Moorjani was a graduate researcher at the Mount Sinai School of Medicine in the doctoral program concentrating on neurobiology.